title: Effects of dobutamine hydrochloride on cardiovascular function in horses anesthetized with isoflurane with or without acepromazine maleate premedication.
abstract: OBJECTIVE To determine the effects of acepromazine maleate premedication on cardiovascular function before and after infusion of dobutamine hydrochloride for 30 minutes in isoflurane-anesthetized horses. ANIMALS 6 healthy adult horses. PROCEDURES Each horse was anesthetized once following premedication with acepromazine (0.02 mg/kg, IV) administered 30 minutes prior to anesthetic induction (ACP+ treatment) and once without premedication (ACP- treatment). Anesthesia was induced with IV administration of xylazine hydrochloride (0.8 mg/kg), ketamine hydrochloride (2.2 mg/kg), and diazepam (0.08 mg/kg). Horses were positioned in right lateral recumbency, and anesthesia was maintained via inhalation of isoflurane delivered in oxygen. End-tidal isoflurane concentration was adjusted to achieve a target mean arterial blood pressure of 60 mm Hg (interquartile range [25th to 75th percentile], 57 to 63 mm Hg) for at least 15 minutes. Cardiac index, oxygen delivery index, and femoral arterial blood flow indices were determined 60 minutes after anesthetic induction (baseline). Dobutamine was then infused to achieve a target mean arterial blood pressure of 80 mm Hg (interquartile range, 76 to 80 mm Hg). Data collection was repeated 30 minutes after the start of dobutamine infusion for comparison with baseline values. RESULTS Complete data sets were available from 5 of the 6 horses. Dobutamine administration resulted in significant increases in oxygen delivery and femoral arterial blood flow indices but no significant change in cardiac index for each treatment. However, at baseline or 30 minutes after the start of dobutamine infusion, findings for the ACP+ and ACP- treatments did not differ. CONCLUSIONS AND CLINICAL RELEVANCE In isoflurane-anesthetized horses, dobutamine administration increased oxygen delivery and femoral arterial blood flow indices, but these changes were unaffected by premedication with acepromazine.
authors.forename: Mara F
authors.initials: MF
authors.lastname: Schier
authors.forename: Anthea L
authors.initials: AL
authors.lastname: Raisis
authors.forename: Cristy J
authors.initials: CJ
authors.lastname: Secombe
authors.forename: Giselle
authors.initials: G
authors.lastname: Hosgood
authors.forename: Gabrielle C
authors.initials: GC
authors.lastname: Musk
authors.forename: Guy D
authors.initials: GD
authors.lastname: Lester
mesh_terms: D000075:Acepromazine / Q000008:administration & dosage; D000758:Anesthesia / Q000662:veterinary; D018685:Anesthetics, Inhalation / Q000008:administration & dosage; D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage; D001794:Blood Pressure / Q000187:drug effects; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D004280:Dobutamine / Q000008:administration & dosage / Q000494:pharmacology*; D004334:Drug Administration Schedule; D006339:Heart Rate / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects; D006736:Horses / Q000502:physiology*; D007262:Infusions, Intravenous / Q000662:veterinary; D007530:Isoflurane / Q000008:administration & dosage; D008297:Male; D011292:Premedication / Q000662:veterinary
chemical_list: D018685:Anesthetics, Inhalation; D014150:Antipsychotic Agents; D002316:Cardiotonic Agents; D004280:Dobutamine; D000075:Acepromazine; D007530:Isoflurane